Elisabeth Defossa

USPTO Granted Patents = 53 (Patent Applications = 6)

EPO Patents = 19 (Patent Applications = 13)

Average Co-Inventor Count = 7.2

ph-index = 8

Forward Citations = 335(Granted Patents)

Inventors with similar research interests:

Location History:

Idstein/Taunus, DE (1995)
Idstein, DE (1995 - 2013)
Frankfurt-am-Main, DE (2010 - 2024)

Company Filing History:

16 out of 1,827

Sanofi-a Ventis Deutschland Gmbh

Hoechst Aktiengesellschaft

patents

4. 9 out of 330

Aventis Pharma Deutschland, Gmbh

Years Active: 1995-2024

Loading Chart...

53 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11897876 - Isoxazolidines as RIPK1 inhibitors and use thereof (2024-02-13),

2. 9156796 - Benzoimidazole-carboxylic acid amide derivatives as APJ receptor modulators (2015-10-13),

3. 8859494 - Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament (2014-10-14),

4. 8748465 - Phenylamino-benzoxazole substituted carboxylic acids, method for their production and use thereof as medicaments (2014-06-10),

5. 8648038 - (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments (2014-02-11),

6. 8530413 - Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments (2013-09-10),

7. 8518875 - (Carboxylalkylenephenyl)phenyloxamides, method for the production thereof and use of same as a medicament (2013-08-27),

8. 8501981 - CXCR2 inhibitors (2013-08-06),

9. 8236810 - Substituted 8-aminoalkylthioxanthines, and their use as inhibitors of dipeptidyl peptidase IV (2012-08-07),

10. 8207146 - Phenothiazine derivative having a double bond, method for the production thereof, and use thereof as a pharmaceutical (2012-06-26),

11. 8163774 - Amide-substituted 8-N-benzimidazoles, method for the production thereof, and use of the same as medicaments (2012-04-24),

12. 8148375 - (Cyclopropylphenyl)phenyloxamides, method for the production thereof, and use of same as a medicament (2012-04-03),

13. 8138207 - Aminocarbonyl-substituted 8-N-benzimidazoles, methods for their preparation and their use in pharmaceutical compositions (2012-03-20),

14. 8003668 - Amino-substituted 8-N-benzimidazoles and methods for their use in blood sugar disorders (2011-08-23),

15. 7888343 - Substituted, bicyclic 8-pyrrolidinoxanthines, and methods for their use as inhibitors of dipeptidyl peptidase (2011-02-15),

Title: Elisabeth Defossa: Pioneering Innovation for a Sustainable Future

Introduction:

Elisabeth Defossa is a trailblazer in the world of inventors, known for her dedication to innovation and relentless pursuit of sustainable solutions. With a remarkable portfolio of 51 patents, Defossa continues to inspire future generations to think creatively and push the boundaries of technology and sustainability. Hailing from Idstein, DE, her impact on the field of invention is truly remarkable.

Latest Patents:

1. Benzoimidazole-carboxylic acid amide derivatives as APJ receptor modulators: Defossa's groundbreaking invention focuses on benzoimidazole-carboxylic acid amide compounds that act as APJ receptor modulators. These compounds have shown promise in treating diseases associated with increased blood pressure. Additionally, they have significant potential as active ingredients in pharmaceuticals.

2. Spirocyclically substituted 1,3-propane dioxide derivatives: Another innovative patent by Defossa includes spirocyclically substituted 1,3-propane dioxide derivatives, and their physiologically compatible salts. These compounds are earmarked for the treatment of diabetes, showcasing Defossa's diverse range of contributions to the medical field.

Career Highlights:

Throughout her illustrious career, Elisabeth Defossa has made significant contributions to renowned companies in the industry. She has worked with Sanofi-Aventis Deutschland GmbH, where her inventive spirit and commitment to sustainability have shone through. Defossa's patents reflect her passion for developing solutions that address pressing global challenges.

Collaborations:

In her pursuit of innovation, Elisabeth Defossa has collaborated with esteemed colleagues such as Andreas W. Herling and Thomas Klabunde. These collaborations have fostered a culture of creativity and excellence, leading to impactful inventions that have the potential to shape the future of technology and healthcare.

Conclusion:

Elisabeth Defossa's remarkable journey as an inventor underscores her unwavering commitment to driving positive change through innovation. Her inventive prowess, coupled with a strong focus on sustainability, sets her apart as a visionary in the world of inventors. Defossa's legacy serves as a beacon of inspiration for aspiring inventors and underscores the transformative power of innovation in creating a more sustainable future.Dot

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

6 patents pending:

Please report any incorrect information to support@idiyas.com

19 patents (EPO):

Please report any incorrect information to support@idiyas.com

13 patents pending (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.